750
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Emergent publics of alcohol and other drug policymaking

, &

References

  • Adams, D., and M. Hess. 2001. “Community in Public Policy: Fad or Foundation?” Australian Journal of Public Administration 60 (2): 13–23. doi:10.1111/ajpa.2001.60.issue-2.
  • Arnstein, S. 1969. “A Ladder of Citizen Participation.” Journal of the American Institute of Planners 35 (4): 216–224. doi:10.1080/01944366908977225.
  • Bacchi, C. 2009. Analysing Policy: What Is the Problem Represented to Be? Sydney: Pearson.
  • Bacchi, C. 2015. “Problematizations in Alcohol Policy.” Contemporary Drug Problems 42 (2): 130–147. doi:10.1177/0091450915576116.
  • Brown, S. 2009. “A New Deficit Model.” Nature Nanotechnology 4: 609–611. doi:10.1038/nnano.2009.278.
  • Crase, L., B. Dollery, and J. Wallis. 2005. “Community Consultation in Public Policy: The Case of the Murray-Darling Basin of Australia.” Australian Journal of Political Science 40 (2): 221–237. doi:10.1080/10361140500129990.
  • Fitzgerald, J. 2015. “Political Fear-Mongering Just Magnifies the Harm Ice Can Do.” The Conversation, April 10. Accessed 30 September 2015. https://theconversation.com/political-fear-mongering-just-magnifies-the-harm-ice-cando-39992
  • Foucault, M. 1988. “The Concern for Truth (A. Sheridan, Trans.).” In Michel Foucault: Politics, Philosophy, Culture. Interviews and Other Writings, 1977– 1984, edited by L. D. Kritzman, 255–267. New York: Routledge.
  • Fraser, S. 2006. “Poetic World-Making: Queer as Folk, Counterpublic Speech and the ‘Reader’.” Sexualities 9 (2): 152–170. doi:10.1177/1363460706063117.
  • Fraser, S., and D. Moore. 2011. “Governing through Problems: The Formulation of Policy on Amphetamine-Type Stimulants (ATS) in Australia.” International Journal of Drug Policy 22 (6): 498–506. doi:10.1016/j.drugpo.2011.09.004.
  • Fraser, S., D. Moore, and H. Keane. 2014. Habits: Remaking Addiction. Basingstoke: Palgrave.
  • Gandey, A. 2003. “US Slams Canada Over Vancouver’s New Drug Injection Site.” Canadian Medical Association Journal 169 (10): 1063.
  • Gray, D., and S. Saggers. 2009. “The Evidence Base for Responding to Substance Misuse in Indigenous Minority Populations.” In Preventing harmful substance use: The evidence base for policy and practice, edited by T. Stockwell, P. Gruenewald, J. Toumbourou and W. Loxley. Chichester: John Wiley & Sons.
  • Gaventa, J., and G. Barrett. 2012. “Mapping the Outcomes of Citizen Engagement.” World Development 40 (12): 2399–2410. doi:10.1016/j.worlddev.2012.05.014.
  • Harchaoui, T., J. Jean, and F. Tarkhani. 2003. Prosperity and Productivity: A Canada-Australia Comparison. Economic Analysis Research Paper Series. Ottawa: Statistics Canada No. 11F0027 No. 018.
  • Ivsins, A., C. Chow, S. Macdonald, T. Stockwell, K. Vallance, D. C. Marsh, W. Michelow, and C. Duff. 2011. “An Examination of Injection Drug Use Trends in Victoria and Vancouver, BC after the Closure of Victoria’s Only Fixed-Site Needle and Syringe Programme.” International Journal of Drug Policy 23 (4): 338–340. doi:10.1016/j.drugpo.2011.11.004.
  • Joseph, M. 2002. Against the Romance of Community. Minneapolis: Minnesota University Press.
  • Jürgens, R. 2005. ‘Nothing about Us without Us’ – Greater, Meaningful Involvement of People Who Use Illegal Drugs: A Public Health, Ethical, and Human Rights Imperative. Toronto: Canadian HIV/AIDS Legal Network, International HIV/AIDS Alliance, Open Society Institute. Accessed 4 August 2015. www.aidsalliance.org/assets/000/000/376/310-1.-Nothing-about-us-without-us-Report-(English)_original.pdf?1405520211
  • Kerr, T., W. Small, W. Peeace, D. Douglas, A. Pierre, and E. Wood. 2006. “Harm Reduction by A ‘User-Run’ Organization: A Case Study of the Vancouver Area Network of Drug Users (VANDU).” International Journal of Drug Policy 17 (2): 61–69. doi:10.1016/j.drugpo.2006.01.003.
  • Kimber, J., K. Dolan, I. van Beek, D. Hedrich, and H. Zurhold. 2003. “Drug Consumption Facilities: An Update Since 2000.” Drug and Alcohol Review 22 (2): 227–233.
  • Khenti, A. 2014. “The Canadian War on Drugs: Structural Violence and Unequal Treatment of Black Canadians.” International Journal of Drug Policy 25 (2): 190–195. doi:10.1016/j.drugpo.2013.12.001.
  • Lancaster, K. 2014. “Social Construction and the Evidence-Based Drug Policy Endeavour.” International Journal of Drug Policy 25 (5): 948–951. doi:10.1016/j.drugpo.2014.01.002.
  • Lancaster, K., K. Duke, and A. Ritter. 2015. “Producing the ‘Problem of Drugs’: A Cross National-Comparison of ‘Recovery’ Discourse in Two Australian and British Reports.” International Journal of Drug Policy 26 (7): 617–625. doi:10.1016/j.drugpo.2015.04.006.
  • Lancaster, K., C. Hughes, J. Chalmers, and A. Ritter. 2012. “More than Problem-Solving: Critical Reflections on the ‘Problematisation’ of Alcohol-Related Violence in Kings Cross.” Drug and Alcohol Review 31 (7): 925–927. doi:10.1111/dar.2012.31.issue-7.
  • Lancaster, K., and A. Ritter. 2014. “Examining the Construction and Representation of Drugs as a Policy Problem in Australia’s National Drug Strategy Documents 1985–2010.” International Journal of Drug Policy 25 (1): 81–87. doi:10.1016/j.drugpo.2013.07.002.
  • Lancaster, K., A. Ritter, and R. Sutherland. 2013. “Public Opinion and Drug Policy in Australia: Engaging the ‘Affected Community’.” Drug and Alcohol Review 32 (1): 60–66. doi:10.1111/j.1465-3362.2012.00497.x.
  • Lancaster, K., K. Seear, and C. Treloar. 2015. “Laws Prohibiting Peer Distribution of Injecting Equipment in Australia: A Critical Analysis of Their Effects.” International Journal of Drug Policy 26 (12): 1198–1206. doi:10.1016/j.drugpo.2015.05.014.
  • Lancaster, K., R. Sutherland, and A. Ritter. 2014. “Examining the Opinions of People Who Use Drugs Towards Drug Policy in Australia.” Drugs: Education, Prevention, and Policy 21 (2): 93–101.
  • Lawrence, H., B. Hausman, and C. Dannenberg. 2014. “Reframing Medicine’s Publics: The Local as a Public of Vaccine Refusal.” Journal of Medical Humanities 35 (2): 111–129. doi:10.1007/s10912-014-9278-4.
  • Macdonald, S., T. Stockwell, and J. Luo. 2010. “The Relationship between Alcohol Problems, Perceived Risks and Attitudes toward Alcohol Policy in Canada.” Drug and Alcohol Review 30 (6): 652–658. doi:10.1111/j.1465-3362.2010.00259.x.
  • MacPherson, D., Z. Mulla, and L. Richardson. 2006. “The Evolution of Drug Policy in Vancouver, Canada: Strategies for Preventing Harm from Psychoactive Substance Use.” International Journal of Drug Policy 17 (2): 127–132. doi:10.1016/j.drugpo.2005.10.006.
  • Mathew-Simmons, F., M. Sunderland, and A. Ritter. 2013. “Exploring the Existence of Drug Policy ‘Ideologies’ in Australia.” Drugs: Education, Prevention, and Policy 20 (3): 258–267.
  • Moore, D., and S. Fraser. 2015. “Causation, Knowledge and Politics: Greater Precision and Rigour Needed in Methamphetamine Research and Policy-Making to Avoid Problem Inflation.” Addiction Research & Theory 23 (2): 89–92. doi:10.3109/16066359.2015.1017571.
  • Moore, D., S. Fraser, J. Törrönen, and M. Eriksson Tinghög. 2015. “Sameness and Difference: Metaphor and Politics in the Constitution of Addiction, Social Exclusion and Gender in Australian and Swedish Drug Policy.” International Journal of Drug Policy 26 (4): 420–428.
  • NCPIC. 2015. “Ice in Australia: An Online Survey of Attitudes and Experiences.” Accessed 17 August 2015. https://ncpic.org.au/news/ice_survey_report/
  • OPMA. 2015. “Helping the Community Tackle Ice.” Media release. Accessed 17 August 2015. www.pm.gov.au/media/2015-08-16/helping-community-tackle-ice
  • Penington, D. (2010). The politics of Illicit Drugs: The War on Drugs can Never Succeed; Where should We Go? Paper presented at The Australasian Professional Society on Alcohol and other Drugs Conference.
  • Quirion, B. 2003. “From Rehabilitation to Risk Management: The Goals of Methadone Programmes in Canada.” International Journal of Drug Policy 14 (3): 247–255. doi:10.1016/S0955-3959(03)00077-X.
  • Race, K. 2009. Pleasure Consuming Medicine: The Queer Politics of Drugs. Durham: Duke University Press.
  • Rance, J., and S. Fraser. 2011. “Accidental Intimacy: Transformative Emotion and the Sydney Medically Supervised Injecting Centre.” Contemporary Drug Problems 38 (1): 121–124.
  • Ritter, A. 2011. “The Role of Research Evidence in Drug Policy Development in Australia.” Politicka misao 48 (5): 141–156.
  • Ritter, A., and G. Bammer. 2010. “Models of Policy-Making and Their Relevance for Drug Research.” Drug and Alcohol Review 29 (4): 352–357. doi:10.1111/j.1465-3362.2009.00155.x.
  • Ritter, A., and J. Cameron. 2006. “A Review of the Efficacy and Effectiveness of Harm Reduction Strategies for Alcohol, Tobacco and Illicit Drugs“. Drug & Alcohol Review 25 (6): 611–624.
  • Ritter, A., K. Lancaster, K. Grech, and P. Reuter. 2011. Monograph No. 21: An Assessment of Illicit Drug Policy in Australia (1985-2010): Themes and Trends. DPMP Monograph Series. Sydney: National Drug and Alcohol Research Centre.
  • Roe, G. 2005. “Harm Reduction as Paradigm: Is Better than Bad Good Enough? The Origins of Harm Reduction.” Critical Public Health 15 (3): 243–250. doi:10.1080/09581590500372188.
  • Seear, K., and S. Fraser. 2014. “The Addict as Victim: Producing the ‘Problem’ of Addiction in Australian Victims of Crime Compensation Laws.” International Journal of Drug Policy 25 (5): 826–835. doi:10.1016/j.drugpo.2014.02.016.
  • Stevens, A., and A. Ritter. 2013. “How Can and Do Empirical Studies Influence Drug Policies? Narratives and Complexity in the Use of Evidence in Policy Making.” Drugs: Education, Prevention and Policy 20 (3): 169–174.
  • Strathdee, S., D. Patrick, S. Currie, P. Cornelisse, M. Rekart, and J. Montaner, et al. 1997. “Needle Exchange is Not Enough: Lessons from the Vancouver Injecting Drug use Study.” AIDS 11 (8): F59–F65.
  • Strike, C., T. Myers, and M. Millson. 2004. “Finding a Place for Needle Exchange Programs.” Critical Public Health 14 (3): 261–275. doi:10.1080/09581590400004386.
  • Temenos, C. 2016. “Mobilizing Drug Policy Activism: Conferences, Convergence Spaces and Ephemeral Fixtures in Social Movement Mobilization.” Space and Polity 20 (1): 124–141.
  • Tiffen, R., and Gittens, R. 2004. How Australia Compares. Cambridge: University of Cambridge Press.
  • Treloar, C., and S. Fraser. 2007. “Public Opinion on Needle and Syringe Programmes: Avoiding Assumptions for Policy and Practice.” Drug and Alcohol Review 26 (4): 355–361. doi:10.1080/09595230701373867.
  • van Beek, I., A. Dakin, J. Kimber, and S. Glimour. 2004. “The Sydney Medically Supervised Injecting Centre: Reducing Harm Associated with Heroin Overdose.” Critical Public Health 14 (4): 391–406.
  • Walden, I. 2015. “Talking Back to Policy: Aboriginal Participation in Policy Making.” PhD unpublished thesis, UNSW Australia.
  • Warner, M. 2002. “Publics and Counterpublics.” Public Culture 14 (1): 49–90. doi:10.1215/08992363-14-1-49.
  • Wodak, A. 2008. “Going Soft on Evidence and Due Process: Canada Adopts US Style Harm Maximization.” International Journal of Drug Policy 19 (3): 226–228. doi:10.1016/j.drugpo.2008.02.008.
  • Wynne, B. 2006. “Public Engagement as a Means of Restoring Public Trust in Science – Hitting the Notes, but Missing the Music?” Community Genetics 9 (3): 211–220. doi:10.1159/000092659.
  • Yamey, G. 2000. “UN Condemns Australian Plans for ‘Safe Injecting Rooms’.” British Medical Journal 320 (7236): 667.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.